Platelet Count and Function during Pediatric Extracorporeal Membrane Oxygenation

Katherine Cashen, Kathleen Meert, Heidi J. Dalton

Research output: Contribution to journalArticlepeer-review

9 Scopus citations


Extracorporeal membrane oxygenation (ECMO) is a form of life support used to treat neonates, children, and adults with cardiorespiratory failure refractory to conventional therapy. This therapy requires the use of anticoagulation to prevent clotting in the extracorporeal circuit, but anticoagulation also increases the risk of bleeding on ECMO. Both bleeding and thrombosis remain significant complications on ECMO and balancing these risks is challenging. Acquired platelet dysfunction is common during ECMO and quantitative and qualitative platelet dysfunction contributes to bleeding risk. Optimal platelet count, function, and transfusion thresholds are not well established during pediatric ECMO. In this review, we provide an overview of hemostatic alterations during ECMO, changes in platelet count and function, platelet monitoring techniques, bleeding risk, and future needs to best optimize patient management and care.

Original languageEnglish
Pages (from-to)357-365
Number of pages9
JournalSeminars in Thrombosis and Hemostasis
Issue number3
StatePublished - Apr 1 2020


  • bleeding
  • extracorporeal membrane oxygenation
  • platelet function
  • platelets
  • thrombosis


Dive into the research topics of 'Platelet Count and Function during Pediatric Extracorporeal Membrane Oxygenation'. Together they form a unique fingerprint.

Cite this